A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects

NCT05875259 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetes Mellitus, Type 2

Interventions

DRUG: BR1019-1
DRUG: BR1019-2
DRUG: BR1019-1 + BR1019-2

Sponsor

Boryung Pharmaceutical Co., Ltd